Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Acrux Ltd
ACRCurrent price
0.054 AUD
-0.00099 AUD (-1.82%)
Last closed
0.054 AUD
Company
www.acrux.com.au
ISIN
AU000000ACR3
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
16 412 093 AUD
Yield for 12 month
+25.58 %
1Y
3Y
5Y
10Y
15Y
ACR
Acrux Limited, together with its subsidiaries, engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause; Dapsone 5% and Dapsone 7.5% which are gels for the treatment of acne vulgaris; and Prilocaine 2.5% and Lidocaine 2.5%, a topical anaesthetic cream. It is also involved in the development of Efinaconazole, a topical solution used to treat fungal infections of toenails; Nitroglycerin 0.4%, an ointment for the treatment of pain caused by chronic anal fissure; and Acyclovir 5%, a cream for the treatment of cold sores. The company was incorporated in 1998 and is based in West Melbourne, Australia. Address: 103-113, Stanley Street, West Melbourne, VIC, Australia, 3003
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.34 AUDP/E ratio
–Dividend Yield
–Current Year
+5 042 219 AUD
Last Year
+8 348 235 AUD
Current Quarter
+675 466 AUD
Last Quarter
+4 366 754 AUD
Current Year
-4 627 234 AUD
Last Year
+1 927 353 AUD
Current Quarter
-2 192 786 AUD
Last Quarter
-2 254 193 AUD
Key Figures ACR
1 year
3 years
5 years
10 years
EBITDA
-8 256 127 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-48.18 %
PEG Ratio
–
Return On Equity TTM
-96.89 %
Wall Street Target Price
0.34 AUD
Revenue TTM
5 042 220 AUD
Book Value
0.011 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-90.3 %
Dividend Yield
–
Gross Profit TTM
4 020 108 AUD
Earnings per share
-0.02 AUD
Diluted Eps TTM
-0.02 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-113.93 %
Dividend Analytics ACR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ACR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
18.08.2015
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ACR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.4611
Price Sales TTM
3.2549
Enterprise Value EBITDA
-1.266
Price Book MRQ
5.147
Financials ACR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ACR
For 52 weeks
0.035 AUD
0.087 AUD
50 Day MA
0.062 AUD
Shares Short Prior Month
–
200 Day MA
0.061 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart